Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial ...
SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...
Yahoo Finance9h
United Kingdom Computed Tomography (CT) Systems Market Outlook to 2033, Focusing on 20-40 slice CT Systems, 64-slice CT Systems and More
Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Computed Tomography (CT) Systems Market Outlook to 2033 - 20-40 slice CT Systems, 64-slice CT Systems and Others" report has been added to ...
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...